Clinical Trial Detail

NCT ID NCT03413995
Title Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations (TRIUMPH)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

prostate adenocarcinoma

Therapies

Rucaparib

Age Groups: adult senior

Additional content available in CKB BOOST